Literature DB >> 20528292

PTSD elderly war veterans: a clinical controlled pilot study.

Pedro Gamito1, Jorge Oliveira, Pedro Rosa, Diogo Morais, Nuno Duarte, Susana Oliveira, Tomaz Saraiva.   

Abstract

Around 25,000 war veterans in Portugal suffer posttraumatic stress disorder (PTSD). This clinically controlled study evaluates virtual reality exposure therapy (VRET) as an alternative procedure to reduce PTSD symptoms. Ten patients were assigned to three groups: VRET, exposure in imagination (EI), and waiting list (WL). The patients were Portuguese veterans from a series of wars fought in former African colonies more than 30 years ago. While the EI group participated in traditional imagination therapy, the VRET group was exposed to a virtual reality (VR) war scenario. Cues such as ambush, mortar blasting, and waiting for rescue were used in the VR. Patients enrolled in the VRET group showed statistical reduction of PTSD-associated disorders like depression and anxiety. Far from being conclusive, this pilot study nonetheless presents some promising data on the use of VRET on old war veteran populations.

Entities:  

Mesh:

Year:  2010        PMID: 20528292     DOI: 10.1089/cyber.2009.0237

Source DB:  PubMed          Journal:  Cyberpsychol Behav Soc Netw        ISSN: 2152-2715


  19 in total

Review 1.  Game-based digital interventions for depression therapy: a systematic review and meta-analysis.

Authors:  Jinhui Li; Yin-Leng Theng; Schubert Foo
Journal:  Cyberpsychol Behav Soc Netw       Date:  2014-05-08

Review 2.  Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults.

Authors:  Jonathan I Bisson; Neil P Roberts; Martin Andrew; Rosalind Cooper; Catrin Lewis
Journal:  Cochrane Database Syst Rev       Date:  2013-12-13

Review 3.  [Psychological consequences of earlier and acute traumatization in the elderly. Clinical presentation, diagnosis, and therapy].

Authors:  K Hucklenbroich; M Burgmer; G Heuft
Journal:  Z Gerontol Geriatr       Date:  2014-04       Impact factor: 1.281

Review 4.  [Psychotherapy for posttraumatic stress disorder in older adults].

Authors:  M Böttche; C Knaevelsrud
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

Review 5.  Systematic Review of the Clinical Application of Exposure Techniques to Community-Dwelling Older Adults with Anxiety.

Authors:  Nimali Jayasinghe; Lucy Finkelstein-Fox; Lili Sar-Graycar; Mary-Jane Ojie; Martha L Bruce; JoAnn Difede
Journal:  Clin Gerontol       Date:  2017-02-06       Impact factor: 2.619

6.  Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.

Authors:  Hollie Melton; Nick Meader; Holly Dale; Kath Wright; Julie Jones-Diette; Melanie Temple; Iram Shah; Karina Lovell; Dean McMillan; Rachel Churchill; Corrado Barbui; Simon Gilbody; Peter Coventry
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

Review 7.  Efficacy of virtual reality exposure therapy in the treatment of PTSD: a systematic review.

Authors:  Raquel Gonçalves; Ana Lúcia Pedrozo; Evandro Silva Freire Coutinho; Ivan Figueira; Paula Ventura
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

Review 8.  Virtual reality exposure-based therapy for the treatment of post-traumatic stress disorder: a review of its efficacy, the adequacy of the treatment protocol, and its acceptability.

Authors:  Cristina Botella; Berenice Serrano; Rosa M Baños; Azucena Garcia-Palacios
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-03       Impact factor: 2.570

Review 9.  Virtual reality exposure therapy for posttraumatic stress disorder (PTSD): a meta-analysis.

Authors:  Oswald D Kothgassner; Andreas Goreis; Johanna X Kafka; Rahel L Van Eickels; Paul L Plener; Anna Felnhofer
Journal:  Eur J Psychotraumatol       Date:  2019-08-19

10.  A meta-analysis on the relationship between self-reported presence and anxiety in virtual reality exposure therapy for anxiety disorders.

Authors:  Yun Ling; Harold T Nefs; Nexhmedin Morina; Ingrid Heynderickx; Willem-Paul Brinkman
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.